# US 2024/0188564 A1 · Antibiofilm formulations and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0188564 A1
- Document ID: US20240188564A1
- Status: Published application
- Kind: A1
- Application number: 18/284,164
- Filed: 2022-03-25
- Published: 2024-06-13
- Earliest claimed: 2021-03-26
- Assignees: Suncor Energy Inc.
- Applicants: Suncor Energy Inc.
- Inventors: Michael Fefer; Jun Liu; Kenneth Ng; Yuichi Terazono; Wenzi Ckurshumova
- Web page: https://patentgrep.com/patent/US20240188564A1

## CPC

- A01N 37/44: containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N 25/30: characterised by the surfactants
- A01N 31/02: Acyclic compounds
- A01N 31/08: Oxygen or sulfur directly attached to an aromatic ring system
- A01N 31/14: Ethers
- A01N 35/02: containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
- A01N 37/36: containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N 45/00: Biocides, pest repellants or attractants, or plant growth regulators, containing compounds having three or more carbocyclic rings condensed among themselves, at least one ring not being a six-membered ring (halogenated hydrocarbons A01N29/08; condensed with heterocyclic rings A01N43/00)
- A01N 59/00: Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N 65/44: Poaceae or Gramineae [Grass family], e.g. bamboo, lemon grass or citronella grass
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS

## Abstract

An antibiofilm composition is provided. The antibiofilm composition includes a polycarboxylic acid derivative or a salt thereof, onto which a hydrophobic group, a poly(ethylene oxide) group and/or a poly(propylene oxide) group is covalently bound, an essential oil, and a biosurfactant.

## Claims

### Claim at position 1

1-70. (canceled)

### Claim 71

An antibiofilm combination, comprising:
a compound of Formula (I):
or a salt thereof, wherein:
R is selected from the group consisting of
(C1-C24)alkyl, (C2-C24)alkenyl, (C2-C24)alkynyl, -(EO)t-(PO)w1-(C1-C24)alkyl, -(EO)t-(PO)w1-(C2-C24)alkenyl, -(EO)t-(PO)w1-(C2-C24)alkynyl,
-(PO)w1-(EO)(C2-C24)alkenyl, -(PO)w1-(EO)(C2-C24)alkynyl, —(CH2)p—OR1, —(CH2)p—NR1R2, —(CH2)p—OC(═O)R1, —(CH2)p—NR2C(═O)R1, (C1-C24)acyl, aryl and a steroidyl group;
each Y1, Y2, Y3 and Y4 is independently selected from the group consisting of —OR3 and —NR3R4;
Y5 is selected from the group consisting of —OR1 and —NR1R2;
each R1 is independently selected from the group consisting of (C1-C24)alkyl,
-(EO)tC1-C24)alkyl, (C2-C24)alkenyl, -(EO)t-(PO)w1-(C1-C24)alkyl, -(EO)t-(PO)w1-(C2-C24)alkenyl, -(EO)t-(PO)w1-(C2-C24)alkynyl,
-(PO)w1-(EO)4C2-C24)alkenyl, -(PO)w1-(EO)(C2-C24)alkynyl, aryl and a steroidyl group;
each R2, R3 and R4 is independently selected from the group consisting of H, (C1-C24)alkyl, (C2-C24)alkenyl, (C2-C24)alkynyl, -(EO)t-(PO)w1-(C1-C24)alkyl, -(EO)t-(PO)w1-C2-C24)alkenyl, -(EO)t-(PO)w1-(C2-C24)alkynyl, -(PO)w1-(EO)t-C1-C24)alkyl,
-(PO)w1-(EO)4C2-C24)alkenyl, -(PO)w1-(EO)t-(C2-C24)alkynyl, aryl and a steroidyl group;
each Z is independently selected from the group consisting of (C2-C6)alkylene, (C3-C6)cycloalkylene and —(CH2)2—O—(CH2)2—O—(CH2)2—;
wherein each (C2-C6)alkylene and (C3-C6)cycloalkylene is independently unsubstituted or substituted by one or more identical or different substituents R5;
wherein each aryl, (C1-C24)alkyl, (C2-C24)alkenyl and (C2-C24)alkynyl is independently unsubstituted or substituted by one or more identical or different substituents R6;
wherein each R5 and each R6 is independently selected from the group consisting of halogen, —OH, —O—(C1-C4)alkyl, CF3, and —CN;
each n is independently 1, 2, 3 or 4;
each p is independently 2, 3 or 4;
each t is independently a number between 1 and 50; and
each w1 is independently a number between 0 and 10.
an essential oil; and
a biosurfactant selected from the group consisting of an alkyl polyglycoside, a rhamnolipid,
a sophorolipid and a combination thereof.

### Claim 72 (depends on 71)

The antibiofilm combination of claim 71, wherein:
each R1 is independently selected from the group consisting of (C8-C18)alkyl and -(EO)t-C8-C18)alkyl;
R2 and R4 are each H; and
each R3 is independently selected from the group consisting of H, (C8-C18)alkyl and (EO)t-(C8-C18)alkyl,
wherein each t is independently a number between 1 and 30.

### Claim 73 (depends on 71)

The antibiofilm combination of claim 71, wherein Z is selected from the group consisting of —CH2—CH2—,
and —(CH2)2—O—(CH2)2—O—(CH2)2—.

### Claim 74 (depends on 71)

The antibiofilm combination of claim 71, wherein n is 1 or 2.

### Claim 75 (depends on 71)

The antibiofilm combination of claim 71, wherein R is

### Claim 76 (depends on 75)

The antibiofilm combination of claim 75, wherein Y1=OH, Y2=OH and Y3=OH.

### Claim 77 (depends on 75)

The antibiofilm combination of claim 75, wherein Y1=Y5, Y2=OH and Y3=OH.

### Claim 78 (depends on 71)

The antibiofilm combination of claim 71, wherein the compound of Formula (I) is:
or a salt thereof.

### Claim 79 (depends on 71)

The antibiofilm combination of claim 71, wherein the compound of Formula (I) is:
or a salt thereof.

### Claim 80 (depends on 71)

The antibiofilm combination of claim 71, wherein R is
(C8-C18)alkyl, (C8-C18)alkenyl, (C8-C18)alkynyl or —(CH2)p—OC(═O)R1, wherein p=2.

### Claim 81

An antibiofilm combination, comprising:
a compound of Formula (IIIA):
or a salt thereof, wherein:
R19 is selected from the group consisting of H, (C1-C24)alkyl, (C2-C24)alkenyl, (C2-C24)alkynyl, -(EO)t-(PO)w1-(C1-C24)alkyl, -(EO)t-(PO)w1-(C2-C24)alkenyl,
-(EO)t-(PO)w1-(C2-C24)alkynyl,
-(PO)w1-(EO)t-(C2-C24)alkenyl and -(PO)w1-(EO)t-(C2-C24)alkynyl,
R18 is selected from the group consisting of H, (C1-C24)alkyl, (C2-C24)alkenyl,
(C2-C24)alkynyl; -(EO)t-(PO)w1-(C1-C24)alkyl, -(EO)t-(PO)w1-(C2-C24)alkenyl,
-(EO)t-(PO)w1-(C2-C24)alkynyl,
-(PO)w1-(EO)t-(C2-C24)alkenyl and -(PO)w1-(EO)t-(C2-C24)alkynyl,
wherein at least one of R18 and R19 is not H;
each (C1-C24)alkyl, (C2-C24)alkenyl and (C2-C24)alkynyl is independently unsubstituted or substituted by one or more identical or different substituents R6;
wherein each R6 is independently selected from the group consisting of halogen, —OH, —O—(C1-C4)alkyl, CF3, and —CN;
each t is independently a number between 1 and 50; and
each w1 is independently a number between 1 and 10;
an essential oil; and
a biosurfactant selected from the group consisting of an alkyl polyglycoside, a rhamnolipid,
a sophorolipid and a combination thereof.

### Claim 82

An antibiofilm combination, comprising:
a compound of Formula (VII):
or a salt thereof, wherein:
R20 is selected from the group consisting of: (C1-C24)alkyl, (C2-C24)alkenyl,
(C2-C24)alkynyl, -(EO)t-(PO)w1-(C1-C24)alkyl, -(EO)t-(PO)w1-(C2-C24)alkenyl,
-(EO)t(PO)w1-(C2-C24)alkynyl, -(PO)w1-(EO)t-(C1-C24)alkyl,
-(PO)w1-(EO)(C2-C24)alkenyl, -(PO)w1-(EO)t-C2-C24)alkynyl,
t is a number between 1 and 50;
u is a number between 1 and 23;
w1 is a number between 0 and 10; and
w2 is a number between 0 and 10;
each (C1-C24)alkyl, (C2-C24)alkenyl and (C2-C24)alkynyl is independently unsubstituted or substituted by one or more identical or different substituents R6;
wherein each R6 is independently selected from the group consisting of halogen, —OH, —O—(C1-C4)alkyl, CF3, and —CN
an essential oil; and
a biosurfactant selected from the group consisting of an alkyl polyglycoside, a rhamnolipid,
a sophorolipid and a combination thereof.

### Claim 83 (depends on 71)

The antibiofilm combination of claim 71, wherein:
the compound of Formula (I) is a polycarboxylic acid compound of Formula (IC) or Formula (TB),
or a salt thereof, wherein:
R1 is a (C8-C18)alkyl;
R3 is H or (C8-C18)alkyl.

### Claim 84 (depends on 71)

The antibiofilm combination of claim 71, wherein the essential oil is selected from the group consisting of thymol, eugenol, geranial, nerol, citral, carvacrol, cinnamaldehyde, terpinol, α-terpinene, citronellal, citronellol, geraniol, geranyl acetate, limonene, lavender oil, methyl isoeugenol and mixtures thereof.

### Claim 85 (depends on 71)

The antibiofilm combination of claim 71, further comprising a surfactant selected from the group consisting of an alkyl sulfate surfactant, an alkylbenzene sulfonate surfactant, an ethoxylated alcohol, a polymeric surfactant, a fatty acid ester, a poly(ethylene glycol), an ethoxylated alkyl alcohol, a monoglyceride, an alkyl monoglyceride, a polysorbate, and a mixture thereof.

### Claim 86 (depends on 71)

The antibiofilm combination of claim 71, which is free of any additional surfactant.

### Claim 87 (depends on 71)

The antibiofilm combination of claim 71, further comprising at least one of water, an additional oil and a non-aqueous solvent, wherein the additional oil is selected from the group of a mineral oil and a vegetable oil.

### Claim 88 (depends on 71)

The antibiofilm combination of claim 71, wherein the antibiofilm combination is an antibiofilm composition.

### Claim 89 (depends on 71)

The antibiofilm combination of claim 71, wherein the antibiofilm combination is provided as a multiple-pack system comprising at least two packs, each one of the two packs comprising at least one separate component of the combination.

### Claim 90 (depends on 71)

A method for disrupting preformed biofilms on a surface or for inhibiting biofilm formation on a surface, comprising applying the antibiofilm combination of claim 71 to the surface.
